adverse events
Showing 9976 - 10000 of >10,000
Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)
Not yet recruiting
- Metastatic Melanoma
- Skin Cancer
- Ipilimumab
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Mar 9, 2023
Breast Cancer Female, Early-stage Breast Cancer Trial in Jette (Trimix, Placebo)
Recruiting
- Breast Cancer Female
- Early-stage Breast Cancer
- Trimix
- Placebo
-
Jette, Brussel, BelgiumUZ Brussel
May 18, 2022
COVID-19 Trial in Baltimore (Emetine Hydrochloride, Placebo)
Not yet recruiting
- COVID-19
- Emetine Hydrochloride
- Placebo
-
Baltimore, MarylandJohns Hopkins University, The Center for TB and AIDS Research
Jun 9, 2023
COVID-19, SARS-CoV-2 Infection Trial in India (BBV152A - Phase I, BBV152B - Phase I, BBV152C - Phase I)
Completed
- COVID-19
- SARS-CoV-2 Infection
- BBV152A - Phase I
- +5 more
-
Visakhapatnam, Andhra Pradesh, India
- +11 more
Aug 17, 2022
Benign Prostatic Hyperplasia Trial (Optilume Catheter System)
Not yet recruiting
- Benign Prostatic Hyperplasia
- Optilume Catheter System
- (no location specified)
Sep 30, 2022
Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in New York (Venetoclax, Tazemetostat)
Not yet recruiting
- Lymphoma, Non-Hodgkin
- +2 more
-
New York, New YorkWeill Cornell Medicine/NewYork-Presberteryian Hospital
Jan 18, 2023
Growth Failure, Congenital Heart Disease Trial in United States (New Infant Formula)
Completed
- Growth Failure
- Congenital Heart Disease
- New Infant Formula
-
Jacksonville, Florida
- +4 more
Dec 7, 2020
Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal
Active, not recruiting
- Platinum-Resistant Fallopian Tube Carcinoma
- +5 more
- Atezolizumab
- +4 more
-
Tucson, Arizona
- +16 more
Oct 19, 2022
Glycogen Storage Disease Type II Pompe Disease Trial in Worldwide (GZ402666)
Completed
- Glycogen Storage Disease Type II Pompe Disease
-
Phoenix, Arizona
- +16 more
Dec 14, 2022
Lichen Sclerosus Trial in Canada, United States (Ruxolitinib cream, Vehicle cream)
Recruiting
- Lichen Sclerosus
- Ruxolitinib cream
- Vehicle cream
-
Birmingham, Alabama
- +4 more
Dec 13, 2022
COVID-19 Trial in Peshawar (Medium-dosage COVID-19 Vaccine,Inactivated, High-dosage COVID-19 Vaccine,Inactivated,
Suspended
- COVID-19
- Medium-dosage COVID-19 Vaccine,Inactivated
- +2 more
-
Peshawar, PakistanCentral Park Teaching Hospital
Aug 9, 2022
Parkinson Disease Trial in Toon (Lu AF28996)
Not yet recruiting
- Parkinson Disease
- Lu AF28996
-
Toon, Ehime, JapanEhime University Hospital
Aug 16, 2023
Dengue Trial in Baltimore (Dengue 4 Live Virus Human Challenge (DENV-4-LVHC) - Low Dose, Dengue 4 Live Virus Human Challenge
Recruiting
- Dengue
- Dengue 4 Live Virus Human Challenge (DENV-4-LVHC) - Low Dose
- +2 more
-
Baltimore, MarylandUniversity of Maryland, Baltimore, Center for Vaccine Developmen
Mar 1, 2022
Retrospective Real World Oxbryta® Data Collection and Analysis
Completed
- Sickle Cell Disease
- Oxbryta® (voxelotor) 500-mg Tablets
-
Farmington, Connecticut
- +8 more
Sep 6, 2022
Advanced Solid Tumor, Metastatic Solid Tumor Trial (ART6043, Olaparib, Talazoparib)
Not yet recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
- ART6043
- +2 more
- (no location specified)
Jun 1, 2023
Prospective, Non-interventional, Multi-center Post-authorization
Recruiting
- Hypertension, Pulmonary
- Riociguat (ADEMPAS, BAY63-2521)
-
Multiple Locations, Japan(unnamed)
Jan 10, 2023
Advanced or Metastatic Solid Tumors Trial (HLX60 combined with HLX10)
Not yet recruiting
- Advanced or Metastatic Solid Tumors
- HLX60 combined with HLX10
- (no location specified)
Aug 1, 2022
Healthy Participants Trial in Lenexa (BMS-986308, Placebo (for BMS-986308), Furosemide)
Completed
- Healthy Participants
- BMS-986308
- +2 more
-
Lenexa, KansasLocal Institution - 0001
Apr 26, 2022
Primary Open-angle Glaucoma Trial in Germany (ARGOS-IO Sensor Pressure System)
Completed
- Primary Open-angle Glaucoma
- ARGOS-IO Sensor Pressure System
-
Aachen, Germany
- +3 more
Jul 11, 2022
COVID-19 Trial in Brisbane (bacTRL-Spike)
Completed
- COVID-19
- bacTRL-Spike
-
Brisbane, Queensland, AustraliaNucleus Network Pty Ltd Brisbane (QPharm)
Oct 24, 2022